Skip to main content
. 2016 Sep 23;5:212301. doi: 10.7573/dic.212301

Figure 2.

Figure 2.

Cost-effectiveness planes for aripiprazole once-monthly 400 mg compared with paliperidone palmitate for (A) QLS and (B) CGI-S.

Scatter plots of bootstrapped incremental costs and effect pairs presented on the incremental cost-effectiveness plane. The southeast quadrant of the cost-effectiveness plane indicates negative costs and positive effects, thus representing the dominant strategy.

CGI-S, Clinical Global Impression–Severity;

QLS, Heinrichs-Carpenter Quality of Life Scale.